Parkinson's Trial NCT06482502
Assess arm endurance measurement reliability
- Trial ID
- NCT06482502
- Official Title
- Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
- Goal
- Assess arm endurance measurement reliability
- Status
- RECRUITING
- Sponsor
- Emre Şenocak
- Study Type
- OBSERVATIONAL
- Enrollment
- 34 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to see whether a simple six minute pegboard and ring test gives valid, repeatable measures of arm endurance in people with Parkinson's. Participants move rings between pegs for six minutes while researchers check how consistent and accurate the results are, this is an observational assessment rather than a treatment so it does not change or interact with medications like levodopa. They are enrolling people aged 45 to 75 with mild to moderate Parkinson's (Hoehn and Yahr stage 3 or lower), who have full shoulder motion, no recent intensive rehab, and no severe heart disease, upper limb orthopedic problems, other neurological diagnoses, uncorrected vision or significant cognitive impairment, and no recent medication changes.
Locations
- İstanbul Medilife Beylikdüzü Hospital, Istanbul, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see whether a simple six minute pegboard and ring test gives valid, repeatable measures of arm endurance in people with Parkinson's. Participants move rings between pegs for six minutes while researchers check how consistent and accurate the results are, this is an observational assessment rather than a treatment so it does not change or interact with medications like levodopa. They are enrolling people aged 45 to 75 with mild to moderate Parkinson's (Hoehn and Yahr stage 3 or lower), who have full shoulder motion, no recent intensive rehab, and no severe heart disease, upper limb orthopedic problems, other neurological diagnoses, uncorrected vision or significant cognitive impairment, and no recent medication changes.
- Who can participate?
- Participants must be between 45 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- How many visits does this trial involve?
- Assessments are done twice on the same day, 1 hour apart, and the same procedure is repeated 2 days later.